Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM120AOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LARP1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAMSAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6IP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM30A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM60A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCTD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUCA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AEBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MERTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF644 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on